Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in.
Sana Biotechnology Inc. (SANA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Integral Health Asset Management Bhagwan Jay Rao | 3,000,000 | $12,210,000 | +50% | 0.61% |
| 2. | Renaissance Technologies Jim Simons | 1,691,116 | $6,882,842 | -16% | 0.01% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 1,679,130 | $6,834,059 | 0.01% | |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,317,641 | $5,362,799 | -5% | 0.02% |
| 5. | AQR Capital Management Cliff Asness | 1,134,324 | $4,616,700 | -5% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 363,637 | $2,000,003.50 | 10,667,387 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.26 | 1,000 | $7,260.00 | 4,541,511 | 2025-01-08 | Filing | |
| $6.71 | 164,912 | $1,106,559.52 | 4,542,511 | 2025-01-08 | Filing | |
| $6.50 | 25,000 | $162,500.00 | 4,707,423 | 2025-01-08 | Filing | |
| $6.11 | 100,000 | $611,000.00 | 4,732,423 | 2025-01-08 | Filing | |
| $3.89 | 150,000 | $583,170.00 | 2,698,121 | 2024-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 37,430,284 | $152,341,256 | 0.01% | |
| 2. | 25,001,856 | $101,757,555 | 31.4% | |
| 3. | 14,223,527 | $57,889,754 | 0% | |
| 4. | 10,455,195 | $42,552,645 | 0% | |
| 5. | 10,242,100 | $41,685,347 | 0.03% |
News See All
12 Best Emerging Technology Stocks to Invest In
On December 24, Kevin Simpson of Capital Wealth Planning joined 'Closing Bell' on CNBC to talk about AI tailwinds and the diverging tech picture.
Sana (SANA) Surges 14.5% Ahead of Business Announcements
In a statement, Sana Biotechnology, Inc.
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength
Sana Biotechnology Inc. (NASDAQ:SANA) is a must-buy penny stock according to analysts.
11 Must-Buy Penny Stocks to Buy Now
Markets have continued to rally, with the S&P 500 already up by about 15% for the year.
Sana Biotechnology Inc. (SANA) Bolsters Management Team
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy now. On September 5, the company confirmed the retirement of Executive Vice President Bernard J.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
Can Sana Biotechnology’s (SANA) Pipeline Momentum Translate into More Share Price Upside?
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to buy right now.
11 Best Emerging Technology Stocks to Buy Right Now
While the telephone brought comfort, smartphones changed lives. While factories powered economies, artificial intelligence began rewriting them.
Top 10 Stocks Under $10 That Could Triple
The Bureau of Labor Statistics reported that only 22,000 jobs were added in August, much less than the 75,000 jobs that economists polled by Dow Jones had expected.
Hedge Fund Resource Center